Melissa A. Maczis

FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice

S. Spiegel, P. Bedossa, A. Sanyal, 2019, Journal of Lipid Research.

FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann‐Pick type C mutant fibroblasts

M. Maceyka, S. Milstien, S. Spiegel, 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Sphingosine kinase 1 mediates sexual dimorphism in fibrosis in a mouse model of NASH

S. Spiegel, J. Allegood, L. Cowart, 2022, Molecular metabolism.

New insights into functions of the sphingosine-1-phosphate transporter SPNS2

M. Maceyka, S. Milstien, S. Spiegel, 2019, Journal of Lipid Research.

Spag17 Deficiency Results in Skeletal Malformations and Bone Abnormalities

G. Sundaresan, R. M. Costanzo, B. Boyan, 2015, PloS one.

Sphingosine-1-phosphate and estrogen signaling in breast cancer.

S. Milstien, S. Spiegel, Melissa A. Maczis, 2016, Advances in biological regulation.

CERAMIDE IN APOPTOSIS AND OXIDATIVE STRESS IN ALLERGIC INFLAMMATION AND ASTHMA.

S. Milstien, S. Spiegel, S. Wenzel, 2020, The Journal of allergy and clinical immunology.

Genome-wide association study identifies a new susceptibility locus in PLA2G4C for Multiple System Atrophy.

Sonja W. Scholz, A. Singleton, Y. Kusakabe, 2023, medRxiv.

Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer

S. Milstien, S. Spiegel, J. Harrell, 2018, Journal of Lipid Research.

Sphingosine kinase 2 in stromal fibroblasts creates a hospitable tumor microenvironment in breast cancer.

S. Milstien, S. Spiegel, M. Dozmorov, 2022, Cancer research.